Neogen Soars After Earnings Beat and Raised Outlook -- Barrons.com

Dow Jones
Jan 08

By Nate Wolf

Shares of Neogen spiked Thursday after the food safety company reported stronger-than-expected quarterly results and boosted its fiscal-year guidance.

Neogen posted adjusted earnings of 10 cents a share for its fiscal second quarter, surpassing analysts' consensus estimate of 6 cents, according to FactSet. Revenue totaled $224.7 million, down 2.8% from the prior year, but ahead of Wall Street's call for $207.7 million.

The company now expects revenue of $845 million to $855 million in fiscal 2026, up from a previous forecast of $820 million to $840 million.

Neogen stock jumped 28% to $9.45 on Thursday, marking the second straight quarter shares have spiked after earnings.

The company revealed a cost-cutting plan and an unspecified number of companywide layoffs last fall, which pleased investors after three consecutive years of net losses. The stock is now up nearly 70% since the start of October, but it remains down 80% from an all-time closing high of $48.34 on April 20, 2021.

Write to Nate Wolf at nate.wolf@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 08, 2026 10:44 ET (15:44 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10